Abstract

Until a few years ago, lymphatic vessels and lymphatic endothelial cells (LEC) were viewed as part of a passive conduit for lymph and immune cells to reach lymph nodes (LN). However, recent work has shown that LEC are active immunological players whose interaction with dendritic cells and T cells is of important immunomodulatory relevance. While the immunological interaction between LEC and other immune cells has taken a center stage, molecular analysis of LEC antigen processing and presentation machinery is still lagging. Herein we review the current knowledge of LEC MHC I and MHC II antigen processing and presentation pathways, Including the role of LEC in antigen phagocytosis, classical, and non-classical MHC II presentation, proteasome processing and MHC I presentation, and cross-presentation. The ultimate goal is to provide an overview of the LEC antigen processing and presentation machinery that constitutes the molecular basis for their role in MHC I and MHC II-restricted immune responses.

Highlights

  • Recent work has shown that lymphatic endothelial cells (LEC) are active immunological players whose interaction with dendritic cells and T cells is of important immunomodulatory relevance

  • Surface expression in lymph nodes (LN)-LEC is similar to what observed in blood endothelial cells (BEC) but less than fibroblastic reticular cells from LN [1]

  • On the other hand the multilamellar bodies (MLB), which are lysosomal-like compartment formed by concentric lamellae and enriched in MHC class II molecules [16] are expressed in professional APCs, such as DCs, B cells and macrophages, and they have not been found in LEC

Read more

Summary

Endothelial Cells

Specialty section: This article was submitted to Immunological Tolerance and Regulation, a section of the journal

Machinery in Lymphatic Endothelial
MHC I and MHC II Molecules
Antigen Presentation by Lymphatic Endothelial Cells
The Proteasome and TAP
TAP deficient mice were much less efficient in presenting
Endosomes and Lysosomes
The MHC II molecules in association with their chaperone
Cystatin A
Mass spectrometry profiles confirmed the presence of an MHC
LEC AND PATHOGEN IMMUNITY
Exogenous Peptides Binding and Antigen
PHAGOCYTOSIS AND AUTOPHAGY
CONCLUDING REMARKS
EXOSOMES AND OTHER VESICLES
Relaxed DM requirements during class II peptide loading and

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.